Jubilant Ingrevia Limited Approves Grant of 3,43,569 Stock Options to Employees
Jubilant Ingrevia Limited announced that its Nomination, Remuneration and Compensation Committee has approved the granting of a total of 3,43,569 Stock Options to eligible employees. The grant is made under the framework of the Jubilant Ingrevia Employees Stock Option Plan 2021.The company confirmed that the stock options cover 3,43,569 Equity Shares of face value Re. 1 each. The exercise price for these options is set at Re. 1 each, which equals the face value per equity share.
According to the details provided, the granted options are structured into two categories: Performance Linked Stock Options and Tenure Linked ESOPs. Specifically, the committee approved the grant of 2,40,497 Performance Linked Stock Options and 1,03,072 Tenure Linked ESOPs.
The stock options are subject to defined vesting criteria and schedules, with vesting scheduled to occur after FY30 Financial Closure, pending the fulfillment of various conditions.
A detailed breakdown of the significant terms and timelines for the stock options is provided below:
| Feature | Performance Linked Stock Options | Tenure Linked Grant |
|---|---|---|
| Vesting Conditions | Vests after FY30 financial closure, subject to defined performance criteria. | Fully vests after FY30 financial closure. |
| Performance Basis | Based on the Company's performance parameters and individual's performance rating. | Retention-linked and based on individual's performance rating. |
| Exercise Period | N/A | 3,43,569 Stock Options shall be exercisable within a period of 1 (one) year from the date of Vesting. |
The scheme operates in accordance with the SEBI (Share Based Employee Benefits) Regulations, 2021. The options are considered fully exercisable within one year from the date of vesting.
JUBLINGREA Stock Price Movement
Shares of Jubilant Ingrevia Limited today slipped by 0.67% to settle at ₹658.75. The stock saw considerable activity on the board, trading on a volume of 235,376 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.